Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Jasper Therapeutics Inc. (JSPR)

Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Jasper Therapeutics to Participate at Upcoming Investor Conferences GlobeNewswire - Wed Nov 13, 3:30PM CST

JSPR : 20.43 (-7.56%)
Jasper Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire - Thu Nov 7, 6:30AM CST

JSPR : 20.43 (-7.56%)
Jasper Therapeutics to Present Preclinical Briquilimab Data at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting GlobeNewswire - Thu Oct 24, 7:00AM CDT

JSPR : 20.43 (-7.56%)
Jasper Therapeutics Announces Further Expansion of Clinical Program in Chronic Spontaneous Urticaria GlobeNewswire - Wed Oct 23, 7:00AM CDT

JSPR : 20.43 (-7.56%)
Jasper Therapeutics Reports Positive Data from SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria GlobeNewswire - Mon Oct 14, 6:00AM CDT

JSPR : 20.43 (-7.56%)
Healthcare - iStock-1346675584
1 'Strong Buy' Small-Cap With 276% Upside Potential Barchart - Mon Jul 15, 9:05AM CDT

As Jasper embarks on promising clinical trials and reports narrower losses, analysts remain bullish, setting ambitious price targets that could indicate substantial returns for investors.

IWM : 228.48 (-1.49%)
$SPX : 5,870.62 (-1.32%)
$IUXX : 20,394.13 (-2.40%)
JSPR : 20.43 (-7.56%)
Author
Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus MarketBeat - Thu Jul 13, 2023

Regulatory filings show Gilead Sciences' purchase of shares in AlloVir and Arcus. Strategic investments in the biotech sector are fairly common to boost growth.

GILD : 88.40 (-4.03%)
AMGN : 283.61 (-4.16%)
BMY : 56.22 (-3.90%)
NVS : 103.06 (-0.33%)
BGNE : 189.23 (-2.10%)
JSPR : 20.43 (-7.56%)
VIGL : 3.19 (+0.31%)
ALVR : 0.5690 (+2.89%)
RCUS : 15.70 (-0.44%)
FLACU : 9.50 (+2.48%)
Wall Street - NYSE Stock Market American Flag
S&P Futures Tick Lower As Investors Await Fed Rate Decision, Snap Plunges on Weak Outlook Barchart - Wed Feb 1, 2023

March S&P 500 futures (ESH23) are trending down -0.41% this morning after three major U.S. benchmark indices finished the regular session higher as market participants weighed up economic data and a slew...

ESH23 : 3,957.05s (-0.09%)
GM : 57.04 (-1.01%)
PHM : 128.89 (-0.42%)
SNAP : 10.60 (-1.49%)
HUSQB.S.DX : 64.680 (-0.22%)
WDC : 62.80 (-0.66%)
EA : 161.36 (-1.68%)
AMD : 134.90 (-2.84%)
JSPR : 20.43 (-7.56%)
TSHA : 2.06 (-9.25%)
Jasper Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium Globe Newswire - Thu Jun 23, 2022

REDWOOD CITY, Calif., June 23, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling cures with...

JSPR : 20.43 (-7.56%)
Jasper Therapeutics Announces Annual Virtual Stockholders Meeting to be Held on Thursday, June 23, 2022 Globe Newswire - Mon Jun 6, 2022

REDWOOD CITY, Calif., June 06, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR), a biotechnology company focused on hematopoietic cell...

JSPR : 20.43 (-7.56%)

Barchart Exclusives

3 Oversold Dividend Aristocrats Ready To Explode in 2025 Barchart - 16 minutes ago
These three companies all have one thing in common: they are all on sale. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot